Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Receivables - Net: 2022

  • ProQR Therapeutics N.V's Receivables - Net was N/A to $57.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $57.4 million, marking a year-over-year change of. This contributed to the annual value of $57,393 for FY2022, which is N/A change from last year.
  • According to the latest figures from Q4 2022, ProQR Therapeutics N.V's Receivables - Net is $57.4 million.
  • Over the past 5 years, ProQR Therapeutics N.V's Receivables - Net peaked at $57.4 million during Q4 2022, and registered a low of $57.4 million during Q4 2022.
  • Over the past 1 years, ProQR Therapeutics N.V's median Receivables - Net value was $57.4 million (recorded in 2022), while the average stood at $57.4 million.